MedTrace Logo

Efficacy of Hyaluronic Acid and Platelet-rich Plasma Combination in Knee Osteoarthritis

NCT03211650 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 174

Last updated 2021-06-14

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of intra-articular injections of combined hyaluronic acid and platelet-rich plasma in knee degenerative joint disease in improving joint function and reducing pain.

Conditions

Interventions

DRUG

hyaluronic Acid + platelet-rich plasma

Intra-articular injections of hyaluronic acid combined with platelet-rich plasma

DRUG

hyaluronic acid

Intra-articular injections of hyaluronic acid

DRUG

platelet-rich plasma

Intra-articular injections of platelet-rich plasma

Sponsors & Collaborators

  • Regen Lab SA

    collaborator INDUSTRY

  • University of Milan

    lead OTHER

Principal Investigators

  • Pietro Randelli, Professor · Azienda Socio Sanitaria Territoriale Centro Specialistico Ortopedico Traumatologico Gaetano Pini - CTO

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-14
Primary Completion
2018-11-30
Completion
2021-03-27

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03211650 on ClinicalTrials.gov